Wang, H.; Zhang, C.; Dong, Z.; Zhu, X.; Zheng, X.; Liu, Z.; Zhou, J.; Yu, S.; Wu, X.; Dong, X.
Using an In Vivo Mouse Model to Determine the Exclusion Criteria of Preexisting Anti-AAV9 Neutralizing Antibody Titer of Pompe Disease Patients in Clinical Trials. Viruses 2024, 16, 400.
https://doi.org/10.3390/v16030400
AMA Style
Wang H, Zhang C, Dong Z, Zhu X, Zheng X, Liu Z, Zhou J, Yu S, Wu X, Dong X.
Using an In Vivo Mouse Model to Determine the Exclusion Criteria of Preexisting Anti-AAV9 Neutralizing Antibody Titer of Pompe Disease Patients in Clinical Trials. Viruses. 2024; 16(3):400.
https://doi.org/10.3390/v16030400
Chicago/Turabian Style
Wang, Hanqing, Cengceng Zhang, Zheyue Dong, Xueyang Zhu, Xuchu Zheng, Ziyang Liu, Jianfang Zhou, Shuangqing Yu, Xiaobing Wu, and Xiaoyan Dong.
2024. "Using an In Vivo Mouse Model to Determine the Exclusion Criteria of Preexisting Anti-AAV9 Neutralizing Antibody Titer of Pompe Disease Patients in Clinical Trials" Viruses 16, no. 3: 400.
https://doi.org/10.3390/v16030400
APA Style
Wang, H., Zhang, C., Dong, Z., Zhu, X., Zheng, X., Liu, Z., Zhou, J., Yu, S., Wu, X., & Dong, X.
(2024). Using an In Vivo Mouse Model to Determine the Exclusion Criteria of Preexisting Anti-AAV9 Neutralizing Antibody Titer of Pompe Disease Patients in Clinical Trials. Viruses, 16(3), 400.
https://doi.org/10.3390/v16030400
